Zacks Investment Research
09 Oct 2026, 12:45 UTC · 1h ago
Impact · against what's priced in
Profound Medical's significant revenue beat and margin expansion provide a positive catalyst for the stock, though the immediate price jump may have already internalized much of the surprise. The impact on CATX is negligible and purely based on sector correlation.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish · 2 new · 1 priced in
Profound Medical provided a preliminary Q3 2026 revenue forecast of $9.8 million to $10 million.
Newpublished Oct 09, 2026; refers to preliminary forecast
So whatThis beat represents a 45% to 47% premium over the $6.78 million Bloomberg consensus.
More positive than 99% of claims this week
The company expects Q3 2026 gross margins to exceed 70%.
Continue reading
5 related stories
Preliminary Q3 revenue of $9.8M-$10M is 45-47% above the Bloomberg consensus of $6.78M, paired with gross margins exceeding 70%.
Read from the article alone
No priced-in read yet
The stock rose 10.2% alongside PROF, likely due to broader sentiment in the medical drugs industry rather than company-specific news.
Read from the article alone
Scored by the NIS engine · methodology.
Newpublished Oct 09, 2026; refers to preliminary forecast
So whatScaling margins alongside 85%+ YoY growth typically reduces the timeline to break-even EPS.
More positive than 93% of claims this week
The consensus EPS estimate for the current quarter has remained unchanged over the last 30 days.
Priced inanalysis of last 30 days of estimates
So whatLack of upward revisions suggests the 21.7% jump may lack sustainable momentum for the next print.
More negative than 69% of claims this week
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
1h ago
+1.2%
Price agrees with the score
$6.99 vs $6.91 close before publication (Oct 8) · not market-adjusted
PROF chart →−1.3%
Price is moving against the score
$2.67 vs $2.71 close before publication (Oct 8) · not market-adjusted
CATX chart →
